Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-19

Clinical Trial Update: Exparel for Pain Control During Care of Rib Fractures [Phase 4]

View source ↗

Summary

Phase 4 trial of Exparel for pain control during care of rib fractures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Michael Moncure, MD | Conditions: Pain | Phase 4 | Status: WITHDRAWN